The Possible Role of Tryptophan in Migraine

  • S. Salmon
  • C. Curradi
  • E. Del Bene
  • F. Sicuteri
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 398)

Abstract

For many years, it has been accepted that the serotoninergic system plays a major role in the modulation of nociception.

Keywords

Placebo High Performance Liquid Chromatography Depression Dopamine Migraine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anselmi B., Baldi E., Casacci F., and Salmon S., 1980, Endogenous opioids in CSF and blood in idiopathic headache sufferers,Headache, 20: 294.CrossRefGoogle Scholar
  2. Bono G., Criscuoli M., Martignoni E., Salmon S., and Nappi G., 1982, Serotonin precursors in migraine patients,in:“Advances in Neurology”, 33, Critchley M. et al. eds., Raven Press, N.YGoogle Scholar
  3. Caleri D., Gatto G., Bonciani M., Curradi C., and Salmon S., 1984, Influence of apomorphine on plasma tryptophan and cAMP in migraine sufferers,IRCS Med. Sci., 12: 142.Google Scholar
  4. Clarke D.E., 1992, A synopsis of the pharmacology of clinically used drugs at 5-HT receptors and uptake sites, in: “5-Hydroxytryptamine Mechanisms in Primary Headaches”, Olesen J., and Saxena P.R., eds., Raven Press, N.YGoogle Scholar
  5. Cowen P.J., 1993, Serotonin receptor subtypes in depression, evidence from studies in neuroendocrine regulation,Clin. Neuropharmacol. (U.S.), 13 suppl. 3: 6.Google Scholar
  6. Goethert M. and Schlicker E., 1990, Modulation of serotonin release in the central nervous system via presynaptic 5HT autoreceptors,in“:Serotonin: from cell biology to phawrmacology and therapeutics”, Paoletti R. et al. eds., Kluwer Academic Publishers, Dordrecht.Google Scholar
  7. Garattini S ., Caccia S., Mennini T., Samanin R., ConsoloS. and Ladinsky H.,1979, Biochemical pharmacology of the anorectic drug fenfluramine: a revue.Curr Med. Res. Opin. 6, suppl. 1: 15CrossRefGoogle Scholar
  8. Pletscher A. 1978, Platelets as a model for monoaminergic neurons,Neurochem. Neuropharmacol., 3: 49.Google Scholar
  9. Poggioni M., Bonazzi A., Del Bene E., and Sicuteri F., 1992, Focus on latent nociceptive dysfunction in humans,in:“Adv. in Pain Res. and Therapy”, 20, Sicuteri F. et al. eds., Raven Press, N.YGoogle Scholar
  10. Raleygh M.J., Brammer G.L., Ritvo E.R., Geller E., McGuire M.T. and Yuwiler A., 1986, Effects of chronic fenfluramine on blood serotonin, cerebrospinal fluid metabolites, and behavior in monkeys,Psychopharmacology, 90: 503.Google Scholar
  11. Salmon S., Fanciullacci M., Bonciani M., Sicuteri F., 1978, Plasma tryptophan in migraine,Headache, 17: 238.CrossRefGoogle Scholar
  12. Salmon S., Bonciani M., Fanciullacci M., Marianelli L., Michelacci S. and Sicuteri F., 1982, A putative 5-HT central feedback in migraine and cluster headache attacks.in:“Advances in Neurology”, 33, Critchley M. et al. eds., Raven Press, N.YGoogle Scholar
  13. Salmon S., Del Re P., Caleri D., Fanciullacci M., and Sicuteri F., 1984, Dynamics of plasma tryptophan following antimigraine drugs.in:“Progress in tryptophan and serotonin research”, Schlossberger H.G. et al., eds., Walter de Gruyter, Berlin-NYGoogle Scholar
  14. Sicuteri F., 1971, Pain syndrome in man following treatment with p-chlorophenilalanine,Pharmacol Res. Commun., 3: 401.CrossRefGoogle Scholar
  15. Sicuteri F ., 1971, Pain syndrome in man following treatment with p-chlorophenilalanine,Pharmacol Res. Commun., 3: 401CrossRefGoogle Scholar
  16. Sicuteri F., Del Bene E., Anselmi B., Fenfluramine headache, 1976,Headache16: 185.CrossRefGoogle Scholar
  17. Sicuteri F., Poggioni M., Panconesi A., Upregulation of pain transmission from deficient serotonergic analgesia in migraine. In: “Serotonin, from cell biology to pharmacology and therapeutics”, Paoletti R. et al. eds., Kluwer Academic Publishers, Dordrecht.Google Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • S. Salmon
    • 1
  • C. Curradi
    • 1
  • E. Del Bene
    • 1
  • F. Sicuteri
    • 1
  1. 1.Institute of Internal Medicine and Therapy IVUniversity of FlorenceFirenzeItaly

Personalised recommendations